Catalyst Wire Dossier Catalyst Wire Dossier

Beclomethasone/salbutamol combination inhaler

· Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Beclomethasone/salbutamol combination inhaler, covering 2020-08-03 to 2020-08-03. Get the full timeline:

Most recent: Clinical Trial Update: As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma [Phase 3]

See pricing